NCT00006981 Immunotoxin Therapy in Treating Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00006482 Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix Status TERMINATED Phase PHASE2
NCT00006224 Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix Status TERMINATED Phase PHASE2
NCT00006083 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Status COMPLETED Phase PHASE3
NCT00006079 Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia Status COMPLETED Phase PHASE2
NCT00005999 Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer Status COMPLETED Phase PHASE2
NCT00005965 Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix Status COMPLETED Phase PHASE2
NCT00005941 Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer Status COMPLETED Phase PHASE2
NCT00005837 Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer Status COMPLETED Phase PHASE2
NCT00005808 Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia Status TERMINATED Phase PHASE1
NCT00005095 Specimen and Data Study for Ovarian Cancer Early Detection and Prevention Status RECRUITING Phase N/A
NCT00005070 Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer Status COMPLETED Phase PHASE2
NCT00004936 MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients Status COMPLETED Phase NA
NCT00004866 DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix Status COMPLETED Phase PHASE2
NCT00004261 EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma Status TERMINATED Phase PHASE1
NCT00004091 Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results Status COMPLETED Phase N/A
NCT00003977 Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer Status COMPLETED Phase PHASE1
NCT00003945 Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Status COMPLETED Phase PHASE3
NCT00003624 Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer Status TERMINATED Phase PHASE2
NCT00003598 UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia Status COMPLETED Phase NA